Eleison Pharmaceuticals
About this raise: Eleison Pharmaceuticals, with a valuation of $75 million, is raising funds on StartEngine. The company is developing advanced solutions for rare cancers, including small-cell lung cancer, pancreatic cancer, brain cancer, and bone cancer. Eleison Pharmaceuticals has one drug candidate in a Phase 3 trial, two other drug candidates Phase 3 ready, and aims to reach commercialization by 2026-27. Edwin J. Thomas founded Eleison Pharmaceuticals in October 2009. The current crowdfunding campaign has a minimum target of $124,000 and a maximum target of $1.24 million. The campaign proceeds will be used for clinical development, manufacturing, working capital, and general corporate purposes.
Investment Overview
Committed : $621
Deal Terms
Total Commitments ($USD)
- Platform
- StartEngine
- Start Date
- 01/08/2025
- Close Date
- 04/09/2025
$124,000
$1,235,000
$600
Convertible Note
Seed
RegCF
$75,000,000
25%
Company & Team
Company
- Year Founded
- 2009
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B2C
- Margin
- Medium
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $25,000,000
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 04/09/2025 | StartEngine | $75,000,000 | $621 | Convertible Note | Active | RegCF |